Elixhauser outperformed Charlson comorbidity index in prognostic value after ACS: insights from a national registry.

导出 LinkOut

翻译打印收藏纠错

作者： Fangyuan,Zhang ^[1] ; Yida,Chiu ^[2] ; Joie,Ensor ^[3] ; Mohamed O,Mohamed ^[4] ; George,Peat ^[5] ; Mamas A,Mamas ^[6]

作者单位： Keele Cardiovascular Research Group, Centre for Prognosis Research, Institutes of Applied Clinical Science and Primary Care and Health Sciences, Keele University, UK. ^[1] Papworth Trials Unit Collaboration, Royal Papworth Hospital, Cambridge, UK. ^[2] Keele Cardiovascular Research Group, Centre for Prognosis Research, Institutes of Applied Clinical Science and Primary Care and Health Sciences, Keele University, UK; School of Medicine, Keele University, UK. ^[3] Keele Cardiovascular Research Group, Centre for Prognosis Research, Institutes of Applied Clinical Science and Primary Care and Health Sciences, Keele University, UK; Department of Cardiology, Royal Stoke University Hospital, Stoke-on-Trent, UK. ^[4] School of Medicine, Keele University, UK. ^[5] Keele Cardiovascular Research Group, Centre for Prognosis Research, Institutes of Applied Clinical Science and Primary Care and Health Sciences, Keele University, UK; Department of Cardiology, Royal Stoke University Hospital, Stoke-on-Trent, UK. Electronic address: mamasmamas1@yahoo.co.uk. ^[6]

关键词 Acute coronary syndrome Charlson score Comorbidity index Elixhauser score Model comparison Model performance